“Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s753. doi:10.25251/r559dc08.